BridgeBio Pharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO

Neil Kumar

CEONeil Kumar

Employees

576

Employees576

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2015

Founded2015

Employees

576

Employees576

BBIO Key Statistics

Market cap

1.54B

Market cap1.54B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.50M

Average volume1.50M

High today

$10.57

High today$10.57

Low today

$9.83

Low today$9.83

Open price

$10.21

Open price$10.21

Volume

1.36M

Volume1.36M

52 Week high

$53.57

52 Week high$53.57

52 Week low

$4.98

52 Week low$4.98

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

BBIO Earnings

-$1.19

-$0.79

-$0.40

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, Pre-Market

ActualExpected Nov 3, Pre-Market

BridgeBio Pharma

Why Robinhood?

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. Show more

BBIO Key Statistics

Analyst ratings

100%

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.